Chia Tai Enterprises International Ltd

03839

Company Profile

  • Business description

    Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of animal health products and chlortetracycline (CTC). The group has two reportable segments: Biotech Business and Investment Business. The Biotech Business segment is involved in the manufacture and/or sale of animal health products and chlortetracycline. The Investment Business segment is engaged in the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. It generates the majority of its revenue from the Biotech Business segment. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.

  • Contact

    16 Harcourt Road
    21st Floor, Far East Finance Centre
    Central
    Hong Kong
    HKG

    T: +852 25201601

    http://www.ctei.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    900

Stocks News & Analysis

stocks

Undervalued ASX healthcare provider

Solid demand profile for global leader.
stocks

SpaceX: What investors need to know about its enormous upcoming IPO

Morningstar launches research coverage of SpaceX.
stocks

Fair value lifts for toll road operator as Aussie fuel supply steadies

An Australian fuel shortage is becoming increasingly unlikely, a relief for ASX toll road operator.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,920.3028.60-0.32%
CAC 408,146.5936.75-0.45%
DAX 4025,003.04101.66-0.40%
Dow JONES (US)51,078.8846.420.09%
FTSE 10010,338.9570.33-0.68%
HKSE25,658.14259.961.02%
NASDAQ27,086.81114.190.42%
Nikkei 22565,833.491,100.84-1.64%
NZX 50 Index13,155.1789.38-0.67%
S&P 5007,599.9619.900.26%
S&P/ASX 2008,682.1024.60-0.28%
SSE Composite Index4,056.531.21-0.03%

Market Movers